SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001086364-12-002988
Filing Date
2012-10-10
Accepted
2012-10-09 17:57:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 onyx.pharmaceuticals.inc..txt SC 13G/A 10526
  Complete submission text file 0001086364-12-002988.txt   12263
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Subject) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45955 | Film No.: 121136072
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies